The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse A 24-Week,Int.,Rand.,Double-blind,Parallel-group,Multi-centre, Plac.-controlled Phase III Study with a 24-Wk Ext.Per.to Eval.the Efficacy and Safety of Dapagliflozin in Comb.with Glimepiride (a Sulphonylurea) in Subjects with Type2 Diab.who Have Inadeq. Glycaemic Control on Glimepiride Therapy Alone
- collapse Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients
- collapse An open label, randomized, two-period, crossover study to assess the effect of food on fixed dose combination dapagliflozin/metformin tablet (5 mg/1000 mg) in healthy male and female volunteers
- collapse A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets
- collapse An epidemiological study to evaluate standard daily practice in managing patients with arterial hypertension and to evaluate patients’ quality of life
- collapse A Randomised, Open Label, Parallel Group, Multicentre, Phase IV Study on the Effect of 8 Weeks Succinate Metoprolol (Betaloc ZOK®) (95 - 190 mg) on Heart Rate in the Stable Angina Patients
- collapse A randomised, double-blind, placebo-controlled Phase I study to assess the tolerability, safety, pharmacokinetic, and pharmacodynamic properties of AZD6482, alone and co-administered with ASA, after single ascending intravenous doses to healthy male subjects
- collapse A Phase I, Single-centre, Single-blind, Randomised, Placebo-controlled, Single-dose study to Assess the Safety, Tolerability and Pharmacokinetics after Single Ascending Intravenous Doses of AZD2927 in Healthy Male Subjects
- collapse A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled Phase II Study to Assess the Effects on Atrial and Ventricular Refractoriness of an Intravenous Infusion of AZD2927 in Patients Undergoing an Invasive Electrophysiological Procedure
- collapse Cholesterol Goal Attainment rate and its associated factors among dyslipidemic Patients on lipid-lowering drug therapy in Korea (CRESCENDO study)
